NCT01361789View on ClinicalTrials.gov

COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Rupture of Anterior Cruciate Ligament

Interventions

DRUG

parecoxib, valdecoxib, etoricoxib

"40 mg parecoxib (Dynastat, Pfizer®) one hour before surgery and 40 mg valdecoxib (prodrug of parecoxib, Bextra, Pfizer®)were given 8 hour after surgery.~After retraction of parecoxib from the market:~Etoricoxib (Arcoxia, MSD) 120 mg given one hour before surgery"

DRUG

Dexamethasone

8 mg IV

DRUG

parecoxib, valdecoxib, parecoxib and dexamethasone

combination of both drugs

Trial Locations (1)

1309

Baerum Hospital, Rud

All Listed Sponsors

lead

Asker & Baerum Hospital

OTHER

NCT01361789 - COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined | Biotech Hunter | Biotech Hunter